STAGE III RECTAL CANCER AJCC V8
Clinical trials for STAGE III RECTAL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III RECTAL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III RECTAL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise in shrinking HER2+ colorectal tumors before surgery
Disease control Recruiting nowThis study tests a drug called zanidatamab given before surgery for people with HER2-positive colorectal cancer. The drug targets cancer cells to help shrink tumors and improve treatment results. About 38 adults with early-stage colon or rectal cancer will take part to see if thi…
Matched conditions: STAGE III RECTAL CANCER AJCC V8
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New PET scan could sharpen view of rectal cancer during treatment
Diagnosis Recruiting nowThis early study tests a special PET scan that uses a radioactive tracer (64Cu-M5A) to highlight rectal cancer cells. The goal is to see if this scan can show tumor extent and response better than standard scans in 15 adults with locally advanced rectal cancer before and after ch…
Matched conditions: STAGE III RECTAL CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated May 16, 2026 08:06 UTC